SS
PLRX icon

SBI Securities’s Pliant Therapeutics PLRX Stock Holding History

SBI Securities’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342 Hold
300
– – ﹤0.01% 3163
2026
Q1 		$378 Sell
300
-20
-6% -$25 ﹤0.01% 2995
2025
Q4 		$390 Hold
320
– – ﹤0.01% 2967
2025
Q3 		$474 Hold
320
– – ﹤0.01% 2991
2025
Q2 		$371 Sell
320
-70
-18% -$99 ﹤0.01% 3087
2025
Q1 		$527 Buy
390
+280
+255% +$1.7K ﹤0.01% 2854
2024
Q4 		$1.45K Buy
+110
New +$1.5K ﹤0.01% 2437

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SBI Securities's PLRX Position: Q2 2026 in Review

SBI Securities held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 300 shares worth $342. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

SBI Securities first reported a position in PLRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.45K in Q4 2024. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • SBI Securities held 300 shares of Pliant Therapeutics worth $342 as of Q2 2026.
  • SBI Securities left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3163 holding.
  • SBI Securities first reported a position in Pliant Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Pliant Therapeutics position peaked at $1.45K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.